Status:
COMPLETED
Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling
Lead Sponsor:
Duke University
Conditions:
COVID-19
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective is to use "network targeted sampling design" to detect active and/or undiagnosed cases of COVID-19 in the community and determine the spread or distribution of 1) active infectio...
Detailed Description
Purpose and objective: The purpose of this study is to use community sampling to detect active, undiagnosed COVID-19 cases and/or determine the spread or distribution of active infection. The objectiv...
Eligibility Criteria
Inclusion
- Positive COVID-19 test result -or- receipt of a coupon from a previous study participant
- Resident of Durham County (for seed participant only)
- Willing to undergo COVID-19 test nasopharyngeal swab for RT-PCR testing and blood draw for COVID-19 antibody testing
- Age 18+
- Speak and understand English
Exclusion
- Currently receiving inpatient treatment for COVID-19
- Unable to consent
Key Trial Info
Start Date :
December 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 25 2022
Estimated Enrollment :
602 Patients enrolled
Trial Details
Trial ID
NCT04437706
Start Date
December 11 2020
End Date
July 25 2022
Last Update
June 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Margaret Pendzich
Durham, North Carolina, United States, 27710